Definition:
Ophthalmic devices refer to medical devices used for diagnosis of eye diseases, related surgeries, and vision correction.
Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.
Company examples: Essilor International, Johnson & Johnson, Bausch Health Companies. Further information on the key players can be found in the Market Shares boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Aug 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
The Ophthalmic Devices market in North America is experiencing steady growth due to several key factors. Customer preferences in the region, along with specific trends in the market, local special circumstances, and underlying macroeconomic factors, are all contributing to the development of the market. Customer preferences in North America play a significant role in the growth of the Ophthalmic Devices market. With an aging population and increasing prevalence of eye diseases such as cataracts and glaucoma, there is a growing demand for ophthalmic devices that can diagnose and treat these conditions. Customers in North America are also becoming more aware of the importance of regular eye examinations and are willing to invest in devices that can help them maintain good eye health. Trends in the Ophthalmic Devices market in North America further contribute to its development. Technological advancements have led to the introduction of innovative devices such as optical coherence tomography (OCT) scanners and femtosecond lasers, which provide more accurate and precise diagnoses and treatments. These advancements not only improve patient outcomes but also increase the efficiency and effectiveness of ophthalmic practices. In addition to customer preferences and market trends, there are also local special circumstances that impact the Ophthalmic Devices market in North America. The region has a well-developed healthcare infrastructure, including a large number of ophthalmic clinics and hospitals. This facilitates the adoption of new technologies and encourages healthcare providers to invest in advanced ophthalmic devices. Moreover, the presence of leading ophthalmic device manufacturers in North America enhances the availability and accessibility of these devices in the market. Underlying macroeconomic factors also contribute to the growth of the Ophthalmic Devices market in North America. The region has a high per capita income and a strong healthcare system, which enables individuals to afford and access ophthalmic devices. Additionally, favorable reimbursement policies and insurance coverage for ophthalmic procedures incentivize patients to seek treatment and invest in ophthalmic devices. In conclusion, the Ophthalmic Devices market in North America is developing due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The aging population, increasing prevalence of eye diseases, and technological advancements are driving the demand for ophthalmic devices in the region. The well-developed healthcare infrastructure, presence of leading manufacturers, and favorable reimbursement policies further contribute to the growth of the market.
Most recent update: Aug 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights